3DBioFibR Inc, a Halifax-based biomaterials developer, and PlantForm Corporation, a biopharmaceutical firm, have received CAD 1.3 million (~USD 966,000) from Next Generation Manufacturing Canada (NGen) to support one-third of their CAD 3.6 million (~USD 2.76 million) project, with the remaining expenses covered by the companies.
The funding will be used to support a project to create the first large-scale dry spinning of recombinant human collagen fibers, which will be integrated into the pharmaceutical and biomedical sectors, among others.
PlantForm and 3DBioFibR aim to reproduce natural collagen fibers to match or surpass their natural strength, a significant stride for the biomaterial and tissue engineering field. Presently, 3DBioFibR leads in creating biomaterials for tissue regeneration, whereas PlantForm focuses on the inexpensive production of high-value vaccines and protein-based drugs via the vivoXPRESS plant-based manufacturing system.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.